about
The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy.Efficacy of baby-CIMT: study protocol for a randomised controlled trial on infants below age 12 months, with clinical signs of unilateral CPIntroduction of the gross motor function classification system in Venezuela--a model for knowledge dissemination.The role of visual stimuli on standing posture in children with bilateral cerebral palsy.Muscle strength does not explain standing ability in children with bilateral spastic cerebral palsy: a cross sectional descriptive study.Efficacy of the small step program in a randomised controlled trial for infants below age 12 months with clinical signs of CP; a study protocolEuropean consensus table 2006 on botulinum toxin for children with cerebral palsy.Does loss of spasticity matter? A 10-year follow-up after selective dorsal rhizotomy in cerebral palsy.Maternal Body Mass Index in Early Pregnancy and Risk of Epilepsy in Offspring.Neuropsychiatric symptoms and problems among children with idiopathic toe-walking.Association Between Maternal Body Mass Index in Early Pregnancy and Incidence of Cerebral Palsy.Does botulinum toxin A improve the walking pattern in children with idiopathic toe-walking?Hand function in relation to brain lesions and corticomotor-projection pattern in children with unilateral cerebral palsy.Intrathecal baclofen treatment an option in X-linked adrenoleukodystrophy.A prospective cohort study investigating gross motor function, pain, and health-related quality of life 17 years after selective dorsal rhizotomy in cerebral palsy.Deep brain stimulation for cerebral palsy, stability of cognitive functioning and what parents think.Diffusion MRI in corticofugal fibers correlates with hand function in unilateral cerebral palsy.Five and 10 minute Apgar scores and risks of cerebral palsy and epilepsy: population based cohort study in Sweden.The effectiveness of Baby-CIMT in infants younger than 12 months with clinical signs of unilateral-cerebral palsy; an explorative study with randomized design.To switch from Botox to Dysport in children with CP, a real world, dose conversion, cost-effectiveness study.The prevalence and course of idiopathic toe-walking in 5-year-old children.Long-term effects of botulinum toxin A in children with cerebral palsy.Maternal Obesity and Cerebral Palsy in Offspring-Reply.Botulinumtoxin A treatment in toddlers with cerebral palsyBotulinum toxin treatment in cerebral palsy: intervention with poor evaluation?Benign paroxysmal torticollis of infancy does not lead to neurological sequelaeThe accommodative process in children with cerebral palsy: different strategies to obtain clear vision at short distanceBotulinum Toxin A Does Not Improve the Results of Cast Treatment for Idiopathic Toe-WalkingWhat has feet to do with it? Pes planus and medial arch height in adults with and without autism spectrum disorderA novel SGCE gene mutation causing myoclonus dystonia in a family with an unusual phenotypeCo-activity during maximum voluntary contraction: a study of four lower-extremity muscles in children with and without cerebral palsySynergistic muscle activation during maximum voluntary contractions in children with and without spastic cerebral palsyOne-minute and five-minute Apgar scores and child developmental health at 5 years of age: a population-based cohort study in British Columbia, Canada.Idiopathic Toe-Walking: Prevalence and Natural History from Birth to Ten Years of AgePrevalence, identification, and interference of pain in young children with cerebral palsy: a population-based studyHealth-related quality of life, pain, and fatigue in young adults with cerebral palsyCognition in Children with Arachnoid CystsGod och jämlik vård för nyanlända barn med CPRisk of intellectual disability in children born appropriate-for-gestational-age at term or post-term: impact of birth weight for gestational age and gestational agePallidal Deep Brain Stimulation in DYT6 Dystonia: Clinical Outcome and Predictive Factors for Motor Improvement
P50
Q35012920-84F959BB-A0F9-4669-95CD-EDF597E1E354Q35182508-87D5B1DC-58CF-43F3-B718-CEB6D80F96A6Q35765030-5F2D045A-61F1-459E-A243-6AB6B758AD5FQ36112018-D12463BA-ABBB-4020-9E32-7454B618F160Q36141046-15BB547D-F937-4328-AB4E-52470447570FQ36181614-B780EBDC-AC44-4ADA-82CD-1BA2B516590AQ36650485-7D8B04D4-301E-48EE-BF7C-A4C5843C3E65Q37876455-9FE48E7C-9B79-4430-92DF-1303736F4F7EQ38849768-00C50546-B5C7-4E8B-A595-3E995D36F50CQ39521062-701C0D29-80CC-4222-B828-4C2139875432Q40304664-99740ADC-2873-44E6-A1D5-5DA27E3A2A81Q42712811-3043FF3F-B1A3-442A-8653-315182D77E35Q43266374-B7AE7787-703F-40C5-9623-43383C0CAB9DQ47679489-CAC52E78-6E4B-4F34-9564-6920FACE28A3Q48055690-B98B37D1-3912-4E25-9571-F19180FD7E62Q48392165-715BE62A-738B-43DD-A04B-5E7CEEB74164Q48954122-E23C6445-612D-4BAA-9B3C-FF2ABBF50FD4Q49522267-8509C15F-62AE-4376-86A0-6B15DA2D9864Q49630579-B3BBD66E-2497-4CF9-9121-A26826A95670Q49919787-69ADA067-A4B3-4FB1-86C3-649BD74AFE19Q50793965-AD6C378B-997E-44A4-8E8D-780FAB9CAA8AQ51658803-F0D7FB73-4287-4D1B-93F2-5BA2639EA707Q54392891-44231E1F-9DCF-45FD-9F0E-C147CFBEEE0EQ61824696-9C2713ED-CF12-4B38-86A9-DEA268368CCCQ61824788-F6D0EF1D-DA3B-4D67-B159-01F9BC999472Q61851239-CE7AB6BB-A4A7-4280-A358-B36B479081B1Q61851240-C7992F47-3380-478D-9437-0686910C4717Q61851241-EAEFB778-82F3-40F9-961D-FE2CDCE2AA24Q61851242-7C7A3FAE-AAB5-4615-956C-4851D8B6C43AQ61851244-4D1FBFC1-067E-4BC1-AFEC-272C811592A1Q61851245-04853C61-55D3-48D7-9491-BC7233AFBBC7Q61851247-5E27D766-76A6-4FB6-B773-C2D9E4240B3CQ64973551-3AA5C6DF-E89B-411D-A971-B1F75CCB0007Q88386162-BDAD7021-FF15-44C1-8179-684979CE1CD8Q90127609-74E74D7E-76E1-47F2-9BEF-61611C22AE23Q91504305-246C7625-CBE6-46C5-B2F3-F19C1FFCB5C5Q91547076-EFA6722E-FCA1-4971-A497-AF5804407DF8Q91549790-9F50BE99-DB6E-4FD7-8AEB-8E5ABB15203CQ91589684-4D80DD3C-62CF-49AE-A809-318179C9531FQ91815524-6BF8E5E8-B312-4405-B2B6-26C111D6A1E7
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Kristina Tedroff
@ast
Kristina Tedroff
@en
Kristina Tedroff
@es
Kristina Tedroff
@nl
type
label
Kristina Tedroff
@ast
Kristina Tedroff
@en
Kristina Tedroff
@es
Kristina Tedroff
@nl
prefLabel
Kristina Tedroff
@ast
Kristina Tedroff
@en
Kristina Tedroff
@es
Kristina Tedroff
@nl
P214
P906
P106
P1153
6506231810
P21
P214
P31
P496
0000-0002-0456-8029
P569
1962-01-01T00:00:00Z
P7859
viaf-41827860